Boccellino et al. [42] compared the serum obtained from 20 NSCLC patients with that of 10 healthy subjects, identifying α2-macroglobulin, α-microglobulin/bikunin and SERPINA1 as potential biomarkers for early diagnosis and surveillance in lung cancer. Here, SERPINA1 is linked to lung carcinoma.